Andie Zheng

Andie Zheng joined Regor with a track record of clinical development in China. She has over 20 years of experience in both international pharmaceutical companies and domestic companies, including Eli Lilly, Wyeth, AstraZeneca, Novartis, Pfizer (China) R&D Center, and Everest. With increasing role and responsibility, she has demonstrated her leadership to advance clinical programs from IND to NDA in multiple therapeutic areas. Before Regor, Andie Zheng was the head of China Development Division II, Jiangsu Hengrui Medicine Co., Ltd.

Andie Zheng was a trained physician with a specialty in gastroenterology. She received her master’s degree in gastroenterology from the Second Military Medical School and a bachelor’s degree in clinical medicine from the medical college, Fu Dan University.